Clinical trials
Recruiting Lymphoma, Large B-Cell, Diffuse trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 11 |
| 2022 | 5 |
| 2023 | 17 |
| 2024 | 17 |
| 2025 | 22 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 106 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 6 |
| National Cancer Institute (NCI) | 6 |
| Merck Sharp & Dohme LLC | 5 |
| Medical College of Wisconsin | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Mayo Clinic | 3 |
| Nurix Therapeutics, Inc. | 3 |
| University of California, Davis | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 106 |
| Lymphoma, Non-Hodgkin | 38 |
| Lymphoma, Follicular | 37 |
| Lymphoma, Mantle-Cell | 34 |
| Lymphoma, B-Cell, Marginal Zone | 24 |
| Lymphoma, B-Cell | 23 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 20 |
| Lymphoma | 20 |
| Burkitt Lymphoma | 15 |
| Waldenstrom Macroglobulinemia | 11 |
Trials
Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.